New heart pump could make complex angioplasty safer for High-Risk patients
NCT ID NCT06373120
First seen Jan 12, 2026 · Last updated May 21, 2026 · Updated 20 times
Summary
This study compares a new heart support device (CorVad) to standard ECMO in 262 high-risk patients with complex coronary artery disease who need angioplasty. The goal is to see if CorVad better maintains heart function and reduces complications during the procedure. Participants have weak hearts (LVEF ≤35% or ≤40% with symptoms) and are not good candidates for bypass surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH-RISK PERCUTANEOUS CORONARY INTERVENTION (HIGH-RISK PCI) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ling Tao
Xi'an, Shannxi, 710032, China
Conditions
Explore the condition pages connected to this study.